CD1a Antibody (NA1/34-HLK) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-63529
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Flow Cytometry
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG2A Clone # NA1/34-HLK
Concentration
0.1 mg/ml
Product Summary for CD1a Antibody (NA1/34-HLK) [FITC]
Immunogen
Human thymocytes
Reactivity Notes
Species Cross Reactivity: Dog, Cynomolgus monkey Use in Canine reported in scientific literature (PMID:31837774).
Specificity
NB100-64852 recognizes the human CD1a cell surface glycoprotein, a 49kD molecule expressed in association with beta 2 microglobulin. CD1a is expressed strongly by cortical thymocytes, and also by Langerhans cells and interdigitating cells.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Scientific Data Images for CD1a Antibody (NA1/34-HLK) [FITC]
Flow Cytometry: CD1a Antibody (NA1/34-HLK) [FITC] [NB100-63529] - Staining of MOLT 4 cells with MOUSE ANTI HUMAN CD1a:FITC.
Applications for CD1a Antibody (NA1/34-HLK) [FITC]
Application
Recommended Usage
Flow Cytometry
1:10-1:1000
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.09% Sodium Azide
Concentration
0.1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CD1a
Long Name
T Cell Surface Glycoprotein CD1a
Alternate Names
CD1a, FCB6, HTA1, R4, T6
Gene Symbol
CD1A
UniProt
Additional CD1a Products
Product Documents for CD1a Antibody (NA1/34-HLK) [FITC]
Product Specific Notices for CD1a Antibody (NA1/34-HLK) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...